ELUMASSIST Trademark

Trademark Overview


On Thursday, November 15, 2018, a trademark application was filed for ELUMASSIST with the United States Patent and Trademark Office. The USPTO has given the ELUMASSIST trademark a serial number of 88194836. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 25, 2022. This trademark is owned by Alkermes Pharma Ireland Limited. The ELUMASSIST trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Health care and medical information services in the field of support program for patients, patient families and caregivers in the administration of pharmaceutical preparations for the treatment of diseases mediated by an opioid receptor, namely, major depressive disorder, chronic depression, severe unipolar recurrent major depressive episodes, dysthymic disorder, depressive neurosis and neurotic depression, melancholic depression, atypical depression, reactive depression, treatment resistant depression, seasonal affective disorder and pediatric depression, premenstrual syndrome, premenstrual dysphoric disorder, hot flashes, bipolar disorders or manic depression, bipolar disorder and cyclothymic disorder, anxiety, post-traumatic stress disorder, obsessive compulsive disorder and borderline personality disorder
elumassist

General Information


Serial Number88194836
Word MarkELUMASSIST
Filing DateThursday, November 15, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 25, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 23, 2019

Trademark Statements


Description of MarkThe mark consists of the words "ElumAssist" with an arc over the word "Assist".
Pseudo MarkELUM ASSIST
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesHealth care and medical information services in the field of support program for patients, patient families and caregivers in the administration of pharmaceutical preparations for the treatment of diseases mediated by an opioid receptor, namely, major depressive disorder, chronic depression, severe unipolar recurrent major depressive episodes, dysthymic disorder, depressive neurosis and neurotic depression, melancholic depression, atypical depression, reactive depression, treatment resistant depression, seasonal affective disorder and pediatric depression, premenstrual syndrome, premenstrual dysphoric disorder, hot flashes, bipolar disorders or manic depression, bipolar disorder and cyclothymic disorder, anxiety, post-traumatic stress disorder, obsessive compulsive disorder and borderline personality disorder

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, December 2, 2018
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAlkermes Pharma Ireland Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDublin
IE

Party NameAlkermes Pharma Ireland Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDublin
IE

Trademark Events


Event DateEvent Description
Monday, July 25, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 25, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, November 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 23, 2021SOU EXTENSION 5 GRANTED
Wednesday, November 17, 2021SOU EXTENSION 5 FILED
Tuesday, November 23, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 17, 2021TEAS EXTENSION RECEIVED
Tuesday, June 8, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 4, 2021SOU EXTENSION 4 GRANTED
Friday, June 4, 2021SOU EXTENSION 4 FILED
Friday, June 4, 2021TEAS EXTENSION RECEIVED
Wednesday, September 23, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 21, 2020SOU EXTENSION 3 GRANTED
Monday, September 21, 2020SOU EXTENSION 3 FILED
Monday, September 21, 2020TEAS EXTENSION RECEIVED
Saturday, April 25, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 23, 2020SOU EXTENSION 2 GRANTED
Thursday, April 23, 2020SOU EXTENSION 2 FILED
Thursday, April 23, 2020TEAS EXTENSION RECEIVED
Tuesday, November 12, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 8, 2019SOU EXTENSION 1 GRANTED
Friday, November 8, 2019SOU EXTENSION 1 FILED
Friday, November 8, 2019TEAS EXTENSION RECEIVED
Tuesday, June 18, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 23, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 23, 2019PUBLISHED FOR OPPOSITION
Wednesday, April 3, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 18, 2019ASSIGNED TO LIE
Thursday, February 21, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 21, 2019EXAMINER'S AMENDMENT ENTERED
Thursday, February 21, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 21, 2019EXAMINERS AMENDMENT E-MAILED
Thursday, February 21, 2019EXAMINERS AMENDMENT -WRITTEN
Wednesday, February 20, 2019ASSIGNED TO EXAMINER
Tuesday, December 4, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Sunday, December 2, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, November 19, 2018NEW APPLICATION ENTERED IN TRAM